🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these profiles directly for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to individuals administering products of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.

Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, marketing, and customer laws, risking penalties, legal action or prison.

Service Reaction and Content Removal

Based on TikTok, the platform has taken down violative content and banned related hashtags and query recommendations. The organization stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Research also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, positive reviews and detailed guides for mixing or injecting at residence.

Within moments of joining one community, a vendor shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience.

Product Details and Pricing

Inside these groups, posts show dark colored parcels with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how long a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Although the research behind retatrutide is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously seen patients injured by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet approved … may subject patients to potentially serious medical dangers”.